Tuesday, July 7, 2026

#Drug Discovery

28 articles

Novo Nordisk Outsources Parkinson's Program as NVIDIA's BioNeMo Turns Drug Discovery Into Infrastructure

Novo Nordisk Outsources Parkinson's Program as NVIDIA's BioNeMo Turns Drug Discovery Into Infrastructure

Salvado•Jun 25, 2026

NVIDIA's BioNeMo Anchors Drug Discovery Stack as Pharma Outsources R&D to AI Platforms

NVIDIA's BioNeMo Anchors Drug Discovery Stack as Pharma Outsources R&D to AI Platforms

Salvado•Jun 19, 2026

NVIDIA BioNeMo Becomes Pharma's AI Backbone as Novo Nordisk Outsources Parkinson's R&D

NVIDIA BioNeMo Becomes Pharma's AI Backbone as Novo Nordisk Outsources Parkinson's R&D

Salvado•Jun 9, 2026

NVIDIA BioNeMo Locks In Pharma Partnerships as Novo Nordisk Outsources Parkinson's Therapy to AI Specialist

NVIDIA BioNeMo Locks In Pharma Partnerships as Novo Nordisk Outsources Parkinson's Therapy to AI Specialist

Salvado•Jun 5, 2026

NVIDIA BioNeMo Locks In Enterprise Drug Discovery as Pharma Shifts R&D to AI Infrastructure

NVIDIA BioNeMo Locks In Enterprise Drug Discovery as Pharma Shifts R&D to AI Infrastructure

Salvado•Jun 1, 2026

NVIDIA's BioNeMo Locks In Pharma Giants as AI Drug Discovery Becomes Table Stakes

NVIDIA's BioNeMo Locks In Pharma Giants as AI Drug Discovery Becomes Table Stakes

Salvado•May 31, 2026

NVIDIA's BioNeMo Becomes Drug Discovery's Default AI Backbone as Big Pharma Outsources Frontier Biology

NVIDIA's BioNeMo Becomes Drug Discovery's Default AI Backbone as Big Pharma Outsources Frontier Biology

Salvado•May 21, 2026

NVIDIA's BioNeMo Emerges as Core Infrastructure Layer as Pharma Rebuilds R&D Around AI Platforms

NVIDIA's BioNeMo Emerges as Core Infrastructure Layer as Pharma Rebuilds R&D Around AI Platforms

Salvado•May 18, 2026

NVIDIA's BioNeMo Becomes Drug Discovery Infrastructure as Eli Lilly, Thermo Fisher Sign On

NVIDIA's BioNeMo Becomes Drug Discovery Infrastructure as Eli Lilly, Thermo Fisher Sign On

Salvado•May 16, 2026

NVIDIA BioNeMo Signs Eli Lilly and Thermo Fisher Deals, Becomes Pharma AI Infrastructure Layer

NVIDIA BioNeMo Signs Eli Lilly and Thermo Fisher Deals, Becomes Pharma AI Infrastructure Layer

Salvado•May 1, 2026

Amgen Merges R&D and AI Under One Executive as Pharma Makes Generative AI Core Infrastructure

Amgen Merges R&D and AI Under One Executive as Pharma Makes Generative AI Core Infrastructure

Salvado•Apr 30, 2026

NVIDIA BioNeMo Locks In Thermo Fisher and Eli Lilly as Biotech AI Platform War Heats Up

NVIDIA BioNeMo Locks In Thermo Fisher and Eli Lilly as Biotech AI Platform War Heats Up

Salvado•Apr 29, 2026

NVIDIA BioNeMo Platform Secures Pharma Partnerships with Lilly and Thermo Fisher

NVIDIA BioNeMo Platform Secures Pharma Partnerships with Lilly and Thermo Fisher

Salvado•Apr 21, 2026

NVIDIA BioNeMo Platform Anchors Wave of Pharma AI Partnerships and Foundation Model Launches

NVIDIA BioNeMo Platform Anchors Wave of Pharma AI Partnerships and Foundation Model Launches

Salvado•Apr 18, 2026

NVIDIA BioNeMo Platform Locks In Eli Lilly and Thermo Fisher for AI Drug Discovery Infrastructure

NVIDIA BioNeMo Platform Locks In Eli Lilly and Thermo Fisher for AI Drug Discovery Infrastructure

Salvado•Apr 17, 2026

NVIDIA's BioNeMo Secures Lilly, Thermo Fisher as Biotech AI Startups Launch Competing Platforms

NVIDIA's BioNeMo Secures Lilly, Thermo Fisher as Biotech AI Startups Launch Competing Platforms

Salvado•Apr 12, 2026

NVIDIA Anchors Biotech AI Platform Through Lilly and Thermo Fisher Partnerships

NVIDIA Anchors Biotech AI Platform Through Lilly and Thermo Fisher Partnerships

Salvado•Apr 11, 2026

NVIDIA BioNeMo Platform Gains Traction with Thermo Fisher, Eli Lilly Partnerships

NVIDIA BioNeMo Platform Gains Traction with Thermo Fisher, Eli Lilly Partnerships

Salvado•Apr 10, 2026

NVIDIA BioNeMo Platform Powers AI Drug Discovery Across Pharma and Biotech Industry

NVIDIA BioNeMo Platform Powers AI Drug Discovery Across Pharma and Biotech Industry

Salvado•Apr 10, 2026

NVIDIA BioNeMo Platform Lands Partnerships with Lilly, Thermo Fisher for Drug Discovery AI

NVIDIA BioNeMo Platform Lands Partnerships with Lilly, Thermo Fisher for Drug Discovery AI

Salvado•Mar 29, 2026